RetroTherapy Overview
- Founded
-
2004
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
RetroTherapy General Information
Description
Developer of ribonucleic acid based therapeutics designed to be used for the treatment of human genetic diseases. The company develops optimal therapeutic candidates to correct the causative mutation of disease by RNA trans splicing , enabling healthcare practitioners to selectively kill cells infected with retroviruses and prevent the spread of disease.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 4519 Gretna Street
- Bethesda, MD 20814
- United States
+1 (301) 000-0000
RetroTherapy Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 01-Mar-2021 | 0000 | Completed | Generating Revenue | ||
| 3. Grant | 01-Jan-2007 | 0000 | Completed | Generating Revenue | ||
| 2. Early Stage VC | 04-Jan-2005 | $50K | $50K | Completed | Generating Revenue | |
| 1. Grant | Completed | Startup |
RetroTherapy Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Lloyd Mitchell MD | Founder, Chief Executive Officer & Chief Scientific Officer |